Categories
Home Based Business

Yelp files antitrust lawsuit against Google [Video]

Yelp filed an antitrust lawsuit against Google on Wednesday, alleging Google used its monopoly to dominate local search and advertising markets.Video above: Judge rules Google has illegal monopoly on online searchingA federal judges ruling that Google violated U.S. antitrust law with its search business earlier in August paved the way for the lawsuit by Yelp, another major tech company that allows users to write reviews of local businesses. Yelp has long raised grievances with Googles search dominance.Our case is about Google, the largest information gatekeeper in existence, putting its heavy thumb on the scale to stifle competition and keep consumers within its own walled garden, Yelp said in an online blog post on Wednesday.CNN has reached out to Google for comment.The lawsuit, filed in federal court in San Francisco, alleges that Google manipulates results to promote its own local search offerings when a customer searches for such results on Google. That allows Google to unfairly outperform its rivals, Yelp said.That means when a user searches up a local restaurant, Google allegedly uses its monopoly power to serve them any and all information from directions to hours to reviews meaning people dont have to click on a single outside source such as Yelp.In other words, Google abuses its monopoly power in general search to keep users within Googles owned ecosystem and prevents them from going to rival sites, the statement said.Yelp claims Google does this because the quality of reviews on Yelp and other services is better. Yelp cited an FTC report that said 32% of reviews on Google have no text, while review text is always required on its own platform.The staggering court defeat for Google in August had the potential to reshape how millions of Americans get their information online. Wednesdays Yelp lawsuit was one of the first steps taken since the decision was handed down by the U.S. District Court of the District of Columbia.Google has historically spent billions on exclusive contracts to become the worlds default search engine allowing it to stomp on any sort of rival from Bing, DuckDuckGo, to even more specialized platforms like Yelp.Specifically, Googles exclusive deals with Apple and other key players in the mobile ecosystem were anticompetitive, U.S. District Judge Amit Mehta wrote in the opinion from earlier this month. Mehta wrote that Google has also charged high prices in search advertising that reflect its monopoly power in search.The court earlier in August did not find that Google has a monopoly in search ads. But Yelp is arguing that Googles monopoly entices local advertising to depend on Google, allowing Google to charge higher fees.Google said in a statement then that it plans to appeal the decision, and that Mehtas opinion recognized Google as the internets best search engine an argument the company had made in court as the reason consumers preferred Google over the competition.CNNs Clare Duffy and Brian Fung contributed to this report.

Categories
Home Based Business

Arctic Web Expands Services to Boost Efficiency for Startups and SMBs Across Europe [Video]

Arctic Web is making headlines with its latest expansion, aimed at helping startups and small-to-medium-sized businesses (SMBs) supercharge their digital presence. With a growing focus on digital transformation, more businesses are seeking custom web development solutions that streamline operations and enhance efficiency. In response, Arctic Web is scaling up its tailored software offerings to meet this rising demand.

Categories
Small Business Lifestyle

Swimmer Ali Truwit makes Paralympics a year after losing lower leg in shark attack while snorkeling [Video]

The first step for swimmer Ali Truwit was overcoming her newfound fear of the one place she had always felt safe the water.Because the sound of water, any sound involving water, instantly triggered flashbacks to the day she swam for her life after being bitten by a shark.She and a friend were snorkeling in the ocean off Turks and Caicos on May 24, 2023, when a shark charged and bit Truwit’s lower left leg. Bleeding and with the shark circling, Truwit went into competitive swim mode and raced 75 yards toward the safety of the boat. Truwit was rushed to the hospital and airlifted to the United States, where she had three surgeries, including one to amputate her leg below the knee.To reclaim her love of the water, she went to the family’s backyard pool. She waded up to her waist, fought off fear and took back control. The plunge not only started her path toward healing but to Paris for the Paralympics.”I love comeback stories,” said the 24-year-old from Darien, Connecticut, who qualified for Paris in the 100 free, 400 free and the 100 back. “I’ve definitely relied on other people’s comeback stories to help me hold on to what feels like a bold and unrealistic hope of fighting off a shark and surviving and losing a limb and making the Paralympics all in a year.”The shark attack ‘we tried to fight back’Her itinerary for that summer involved fun and adventure before starting work at a consulting firm.Truwit had just graduated from Yale after a career in the pool in which she was a four-year letter winner. She kicked things off by running a marathon with her mom on Mother’s Day.Next on the list: joining friends for some sun on the beaches in Turks and Caicos. She went snorkeling with Yale teammate and good friend Sophie Pilkinton in an area not known for sharks.On their way back to the boat, a shark aggressively approached and began bumping them.”We tried to fight back,” Truwit said.What was believed to be a bull shark bit her on the foot and lower leg.”My immediate thought was, ‘Am I crazy or do I not have a foot right now?'” Truwit said. “It was a really hard image for me. But you move immediately into action.”Stay calm. Remain conscious. Just get to the boat. That’s all she focused on as she and Pilkinton sprinted through the water, intensely aware the shark was still there.Once on the boat, Pilkinton applied a tourniquet to slow the bleeding.Truwit was later airlifted to a trauma hospital in Miami for two surgeries to fight infections. She was transported to a hospital in New York, where on her 23rd birthday, she underwent a transtibial below-the-knee amputation.”A lot of dark days,” she said. “But I’m alive and I almost wasn’t.”‘Work works’ becomes the mantra for recoveryThe Truwit family has a mantra “Work works.” That’s why Truwit went to rehab even on days when she didn’t feel good or was sad.”Just put in the work,” she said.First, though, she needed to alter her “Why?”Instead of, “Why did this happen to me?” she centered on, “Why not throw everything into something?”More specifically, why not the Paralympics? After all, she had plenty of time to get ready for the 2028 Summer Paralympics in Los Angeles.”But I’m not someone who waits,” she said.So Paris in 2024 it was, even if the time frame was incredibly tight.She went through prosthetic training and strength exercises. She also worked with trauma therapists, which led to narrative therapy to re-author her life and combat her nightmares.”So that I don’t let fear rule my life,” Truwit explained. “I had lost enough and anything that was on the table for me to regain, I was going to fight to regain it.”I didn’t want to lose a limb and my love of the water, too.”Focus on making Team USA for ParisAbout 3 1/2 months removed from the attack, she was competing again. It was early but necessary to make certain standards to be in contention for a Paralympic spot. To help her, she teamed up with her club coach, Jamie Barone.”I was just really curious how I was going to feel being back on the pool deck and back in a competitive space,” Truwit said. “The more I worked at it, the flashbacks reduced and the pain lessened.”She qualified for nationals in Orlando, Florida, where she swam freestyle and backstroke. In April, she attended an international meet in Portugal her first trip out of the country since the shark attack. Her mom was there as she shined in the 400 free S10 category, in which swimmers have a physical impairment affecting one of their joints.”She’s just basically a workhorse who refuses to give up,” said her mom, Jody. “That’s who she was before the attack and amputation and that’s who she is every single day now.”At U.S. Paralympic trials in Minneapolis in late June, she won the 100 backstroke, 400 free and 100 free. She joins a team that includes Paralympic swimming great Jessica Long and a host of returning medalists from Tokyo.”I think hearing my name on that team was just a reminder to me that I’m stronger than I think,” said Truwit, who launched the “Stronger Than You Think” foundation to help others navigate through the healing process. “That we’re all stronger than we think.”In Paris, she will have the support of about 50 family members and friends.”A year ago, I was just working to get back in the water,” Truwit said. “I now get back in the water and that sense of joy comes back, and the smile comes back. To have that again is something I’m so thankful for. Honestly, it’s one of the moments in my swim career that I’m the proudest of, because I know how much work it took.”___AP video journalist Aron Ranen contributed to this report.

Categories
Small Business Lifestyle

Lilly launches lower-price weight-loss drug without injector pen [Video]

Starter doses of the weight-loss drug Zepbound are now available in single-dose vials, drug manufacturer Eli Lilly announced Tuesday, a move the company says will significantly expand supply as it sees continued high demand.Instead of a preloaded injector pen, patients will use a syringe to draw out the medicine.Tirzepatide, the active ingredient in Zepbound and Mounjaro, is part of new class of medications used to treat obesity and diabetes that have skyrocketed in popularity, driving shortages and leading some people to use versions made by compounding pharmacies.These new vials not only help us meet the high demand for our obesity medicine, but also broaden access for patients seeking a safe and effective treatment option, Patrik Jonsson, president of Lilly Cardiometabolic Health and Lilly USA, said in a statement.The new vials will be available exclusively to people who pay out of pocket through LillyDirect, a company platform that helps coordinate telehealth services and fill prescriptions for patients.A four-week supply of 2.5-milligram (mg) vials is $399, and a four-week supply of 5-mg vials is $529, less than half the list price of other GLP-1 medicines for obesity, according to Eli Lilly.These prices are in line with those offered through Lillys savings program for uninsured people, the company said. But the option to pay out-of-pocket for the vials now expands access to patients who arent eligible for the savings program, such as those on Medicare.Despite obesity being recognized as a serious chronic illness with long-term consequences, its often misclassified as a lifestyle choice, resulting in many employers and the federal government excluding medications like Zepbound from insurance coverage, Jonsson said. Outdated policies and lack of coverage for obesity medications create an urgent need for more innovative solutions. Bringing Zepbound single-dose vials to patients will help more people living with obesity manage this chronic condition. We will also continue to advocate for a system that better aligns with the science.Tirzepatide works by mimicking hormones that stimulate the release of insulin, increase feelings of fullness and reduce appetite. It targets two hormone receptors, GIP and GLP-1. Semgalutide, known as Ozempic for diabetes and Wegovy for weight loss, is also part of this broad class of drugs.The ongoing shortages of tirzepatide and other popular weight-loss drugs have allowed for compounded versions of the treatments with similar or related ingredients to hit the market, with less oversight and regulation from the U.S. Food and Drug Administration.The FDA has issued a warning last month about compounded versions of semaglutide; the agency says that it has received reports of adverse events some requiring hospitalization due to dosing errors related to units of measurement, varying product concentrations and use of multiple-dose vials. Patients should not use a compounded drug if an approved drug is available, the agency has said.Eli Lilly has also raised concerns about the potential risks that compounded versions of its drugs pose to patients. In an open letter in June, the company emphasized that it is the only lawful supplier of FDA-approved tirzepatide medicines and that products from other unverified sources may be fake, counterfeit, or otherwise unsafe products. is our number one priority, and this is a great way for patients to know theyre getting genuine Lilly medicine, said Rhonda Pacheco, group vice president for Lilly U.S. Cardiometabolic Health. Thousands of people use LillyDirect each week, she said.The experience for people who self-inject tirzepatide with a syringe that was filled from a vial would probably be similar to using a prefilled pen and it might come with some added benefits, said Dr. Jody Dushay, an endocrinologist at Beth Israel Deaconess Medical Center and assistant professor of medicine at Harvard Medical School.Its old school, but I have patients with type 1 and 2 diabetes who prefer vial and syringe to pen devices. I dont think it is a much bigger deal to use an insulin syringe vs auto injector, unless someone has severe needle phobia, she wrote in an email. Its not that difficult to draw up a syringe, although the elderly, those with limited dexterity, and those with poor vision will be better off with the auto injector.The syringe and vial might actually allow for some added flexibility in doses, especially for starting levels, Dushay said. Patients could draw up less than 2.5 mg if theyre having severe side effects or less than 5 mg if theyre ready to increase but not quite double the dose.Also, most compounded versions of tirzepatide come in vials, so patients should be especially careful with the source of their medication, she noted.Clinical trial data found that people using 5-mg injections of tirzepatide lost about 15% of their weight after more than a year of treatment, on average.Another recent study found that people using tirzepatide injections lost more weight and were more likely to reach specific weight loss targets than those on semaglutide.

Categories
Small Business Lifestyle

Louisiana sheriff searching for home invasion suspects [Video]

WDSU NEWS, ANUM. THANK YOU. RIGHT NOW, THE SEARCH IS ON FOR THREE SUSPECTS WHO DEPUTIES SAY ARE BEHIND A HOME INVASION IN PONCHATOULA. GET THIS HOLDING THE FAMILY INSIDE AT GUNPOINT. THE TANGIPAHOA PARISH SHERIFFS OFFICE SAYS JUST AFTER MIDNIGHT ON SUNDAY, THREE MASKED PEOPLE BROKE INTO THAT HOME ON WOOD AVENUE IN THE BLYTHEWOOD SUBDIVISION. WERE TOLD THAT THOSE SUSPECTS ALSO STOLE CASH AND OTHER ITEMS. GETTING AWAY IN A GRAY OR WHITE NISSAN ALTIMA. DETECTIVES SAY THAT THIS MAY HAVE BEEN A TARGETED CRIME, SO IF YOU KNOW ANYTHING THAT CAN HELP, CALL CRIME STOPPERS AT THE PHONE NUMBER RIGHT THERE ON YOUR